Clinical Trials Browser

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

Head and Neck Neoplasms, Lung Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Laryngeal Diseases

Oropharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Breast Neoplasms, Head and Neck Neoplasms, Colorectal Neoplasms

Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Nasopharyngeal Carcinoma, Neoplastic Cells, Circulating

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck, Papillomavirus Infections

Squamous Cell Carcinoma of Head and Neck, Salivary Gland Neoplasms, Tongue Neoplasms

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms

Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms

Laryngeal Diseases, Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Mouth Neoplasms

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Head and Neck Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Leukoplakia, Oral

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

Nasopharyngeal Carcinoma

Squamous Cell Carcinoma of Head and Neck, Laryngeal Diseases

Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Nasopharyngeal Carcinoma

Nasopharyngeal Neoplasms

Nasopharyngeal Carcinoma

Clinical Trials

Individualized Treatment Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

ATATcH Alternating Treatment Plans for Advanced Cancer

5-Fluorouracil Response and Optimization STudy (The FROST Trial)

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma

MEDINDUCTION

Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer

RePaIr-HN

REDUCE

Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma

Induction Chemotherapy With Nab-paclitaxel, Cisplatin and Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma

DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment

Tislelizumab Combined APF Chemotherapy in the Treatment of Locally Advanced Head and Neck Tumors

SALTORL

TPFmORL

Pembrolizumab in Combination With Low-dose PFas Neoadjuvant Treatment for Locally Advanced HNSCC

ECHO-07

DEPEND

OPTIMA-II

Chemotherapy Followed by Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Locally Advanced Head And Neck Cancer

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

A Phase II Study of TPF With PD-1 Inhibitor Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma

GP Vs PF As Induction Chemotherapy Combined with CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma

NEOPBOSCC

Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer

OPTIMA

Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer

NPC-Nivo

Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC

A Multicenter Study of Intensive Concomitant Chemoradiotherapy With Filgrastim (GCSF) for Patients With Locoregionally Advanced Head and Neck Cancer

Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC

Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCC

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Toripalimab in Combined With Cetuximab，Chemotherapy for Conversion Therapy of Locally Nonresectable OCSCC

Neoadjuvant Treatment of Tislelizumab Combined Chemotherapy for Locally Advanced Oral Squamous Cell Carcinoma ：A Single-arm, Prospective, Phase II Trial

5-FU

TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma

A Multi-center, Randomized, Double-blind, Phase III Clinical Trial of Leucogen Versus Placebo on Leukocyte and Platelet Whole-course Management Assisted by PFLL Chemotherapy in the Treatment of Stage IV, Recurrent or Metastatic NPC

OL_5FU

TPExtreme

ELANFIT

A Two-blinded, Multicentre, Phase II/III RCT of Concurrent Chemo-radiotherapy Combined or Not Combined With TNF as the Therapy for LA-NPC

HNO-2

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer

Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma

Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma

Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma